Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-14 to 2022-09-17
Current total value of award: $1694.39
Description: PHARMACODYNAMICS OF THE MAS-RELATED GENE X2 (MRGX2) ANTAGONIST SYR268215 IN THE HUMANIZED MRGX2 KNOCK-IN (KI) MOUSE